Evidence map›Paper›PMID 40768322›Full record

ArticleMolecular biology of the cell2025

Loss of REP-1 in retinal pigment epithelial cells leads to impaired phagosome processing and altered lysosomal pathway function.

Rita Coelho, Pedro Antas, Ana Fragoso Fonseca, Daniela Oliveira, Cláudia Carvalho, Margarida L Pedro, Michael J Hall, Ana Sofia Falcão, Miguel C Seabra, Mafalda Lopes-da-Silva

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rita CoelhoiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Pedro AntasiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Ana Fragoso FonsecaiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Daniela OliveiraiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Cláudia CarvalhoChampalimaud Research, Champalimaud Foundation, Lisbon, Portugal 1169.
Margarida L PedroiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Michael J HalliNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Ana Sofia FalcãoiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Miguel C SeabraiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.
Mafalda Lopes-da-SilvaiNOVA4Health, NOVA Medical School Universidade NOVA de Lisboa, Lisbon, Portugal 1169.ORCID 0000-0001-7651-8656

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Choroideremia (CHM) is a rare form of retinal degeneration caused by mutations in the ubiquitously expressed

Indexed as

Adaptor Proteins, Signal TransducingLysosomesPhagosomesRetinal Pigment EpitheliumVesicular Transport ProteinsCell LineChoroideremiaEpithelial CellsHumansPhagocytosisrab GTP-Binding ProteinsRetinal Photoreceptor Cell Outer SegmentAdaptor Proteins, Signal TransducingCHM protein, humanrab GTP-Binding ProteinsVesicular Transport Proteins

Identifiers

PMID40768322
PMCPMC12415606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.